Filing Details
- Accession Number:
- 0001415889-25-008106
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-14 16:30:15
- Reporting Period:
- 2025-03-12
- Filing Date:
- 2025-03-14
- Accepted Time:
- 2025-03-14 16:30:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1808158 | Repare Therapeutics Inc. | RPTX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1815428 | Steve Forte | C/O Repare Therapeutics Inc. St-Laurent A8 H4S 1Z9 | Evp, Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Disposition | 2025-03-12 | 6,884 | $1.14 | 54,786 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represent shares sold to satisfy the Reporting Person's tax withholding obligation in connection with the vesting and settlement of restricted stock units and does not represent a discretionary sale by the holder.